Suven Pharmaceuticals Renamed as Cohance Lifesciences
ECONOMY & POLICY

Suven Pharmaceuticals Renamed as Cohance Lifesciences

Suven Pharmaceuticals, an integrated CDMO serving customers across the globe, has rebranded as Cohance Lifesciences.

This event represents more than just a name change—it marks a bold step forward in the company’s evolution into a specialized, technology-driven global CDMO platform, purpose-built for the future of therapeutics.

The Cohance name captures the organization’s commitment to Collaborate with global innovators to Enhance their molecules and products to deliver transformative solutions to patients and consumers worldwide.

"The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world" said Cohance Executive Chairman, Vivek Sharma.

The Ministry of Corporate Affairs, Government of India (“MCA”), has approved change of name of the Company from “Suven Pharmaceuticals” to “Cohance Lifesciences”, with effect from May 7, 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.

The Company would make necessary application to the BSE and the National Stock Exchange of India Limited for effecting change of name of the Company in due course. We further inform that the Name Clause of the Memorandum of Association of the Company stands altered accordingly, and the name “Suven Pharmaceuticals” wherever it appears in the Memorandum of Association and the Articles of Association, gets replaced with the new name “Cohance Lifesciences.”

Suven Pharmaceuticals, an integrated CDMO serving customers across the globe, has rebranded as Cohance Lifesciences. This event represents more than just a name change—it marks a bold step forward in the company’s evolution into a specialized, technology-driven global CDMO platform, purpose-built for the future of therapeutics. The Cohance name captures the organization’s commitment to Collaborate with global innovators to Enhance their molecules and products to deliver transformative solutions to patients and consumers worldwide. The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world said Cohance Executive Chairman, Vivek Sharma. The Ministry of Corporate Affairs, Government of India (“MCA”), has approved change of name of the Company from “Suven Pharmaceuticals” to “Cohance Lifesciences”, with effect from May 7, 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation. The Company would make necessary application to the BSE and the National Stock Exchange of India Limited for effecting change of name of the Company in due course. We further inform that the Name Clause of the Memorandum of Association of the Company stands altered accordingly, and the name “Suven Pharmaceuticals” wherever it appears in the Memorandum of Association and the Articles of Association, gets replaced with the new name “Cohance Lifesciences.”

Next Story
Resources

KEC International bags Rs 10.34 billion in new orders

"KEC International Ltd, a global infrastructure EPC major and part of the RPG Group, has secured new orders worth Rs 10.34 billion across its Transmission & Distribution (T&D), Civil, and Cables businesses. In the T&D segment, the company has received its first-ever STATCOM project from a global OEM in India, along with orders for the supply of towers, hardware, and poles in the Americas. The civil business has marked a key milestone by entering the semiconductor space, bagging a contract to establish a semiconductor plant for a major private player. It has also won a repeat order ..

Next Story
Products

Viva launches 3D louvres for next-gen façade design

Viva, Asia’s largest manufacturer of aluminium composite panels (ACP), has introduced its advanced 3D louvres, offering a blend of architectural innovation and practical performance. Designed to enhance the aesthetics and efficiency of building facades, these louvres aim to set a new benchmark for the industry.The newly launched 3D louvres are engineered to add visual depth and dynamic appeal to both residential and commercial structures. Combining durability, ease of installation, and low maintenance, the product is tailored for contemporary design needs.“The 3D louvre range is a natural ..

Next Story
Infrastructure Urban

JustDeliveries raises Rs 5.5 crore to expand intracity cold chain network

JustDeliveries, a cold chain logistics startup focused on mid-mile solutions for India’s food and beverage sector, has raised Rs 5.5 crore in a funding round co-led by VC Grid and NABVentures. Other participants included LetsVenture, Anay Ventures, and FAAD Network.This fresh round brings the total capital raised by the startup to US$ 2 million (approximately Rs 15.9 crore). The funds will be used to strengthen its technology platform and expand operations to three more cities, including Lucknow and Chennai. JustDeliveries currently operates in Bangalore, Delhi, Hyderabad, Mumbai, and Pune.F..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?